WallStreetZenWallStreetZen

NASDAQ: ACST
Acasti Pharma Inc Stock Ownership - Who owns Acasti Pharma?

Insider buying vs selling

Have Acasti Pharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Vimal KavuruDirector2023-09-25676,371$1.85
$1.25MBuy
Donald OldsDirector2023-08-31381$2.05
$781.05Buy

1 of 1

ACST insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACST insiders and whales buy or sell their stock.

ACST Shareholders

What type of owners hold Acasti Pharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Grace 2018 Irrevocable Trust Rajitha49.89%4,689,547$13.32MInsider
Adar1 Capital Management LLC10.21%959,571$2.73MInsider
Aigh Capital Management LLC5.29%497,359$1.41MInstitution
Bank Of America Corp5.26%494,698$1.40MInstitution
George Kottayil5.26%494,698$1.40MInsider
William A. Haseltine3.54%332,836$945.25kInsider
Adar1 Capital Management LLC2.31%217,381$617.36kInstitution
Prashant Kohli1.36%128,138$363.91kInsider
Vimal Kavuru1.32%124,344$353.14kInsider
John Canan1.06%100,000$284.00kInsider

1 of 3

ACST vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACST13.46%74.93%Net Buying
SABS6.01%93.99%Net Buying
RNXT1.38%14.26%Net Buying
CLNN9.73%90.27%Net BuyingNet Selling
BOLT54.60%45.40%Net Selling

Acasti Pharma Stock Ownership FAQ

Who owns Acasti Pharma?

Acasti Pharma (NASDAQ: ACST) is owned by 13.46% institutional shareholders, 74.93% Acasti Pharma insiders, and 11.61% retail investors. Grace 2018 Irrevocable Trust Rajitha is the largest individual Acasti Pharma shareholder, owning 4.69M shares representing 49.89% of the company. Grace 2018 Irrevocable Trust Rajitha's Acasti Pharma shares are currently valued at $13.32M.

If you're new to stock investing, here's how to buy Acasti Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.